Literature DB >> 19187107

Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.

Limin Yu1, Anjela Galan, Jennifer M McNiff.   

Abstract

BACKGROUND: Superficial skin biopsies of basal cell carcinoma (BCC) represent some of the most common dermatopathology specimens. Superficial shave biopsies containing partial samples of lesions with squamatization present difficulties in distinguishing BCC from squamous cell carcinoma (SCC). BerEP4 has been employed as a dependable marker in differentiating between BCCs and SCCs.
METHODS: We collected 12 cases of superficial biopsies of BCC with centrally located cords and strands suggesting squamous differentiation at the Yale Dermatopathology Laboratory over a 3-month period and stained them with BerEP4.
RESULTS: We found that all cases (12 out of 12) showed membranous and cytoplasmic staining with BerEP4 in the obvious areas of basaloid differentiation at the periphery of the tumors, while cords and strands of enlarged cells with squamoid features in the center and surface of the biopsy failed to label with BerEP4.
CONCLUSIONS: BerEP4 labeling is not reliable in superficial biopsies of BCC with squamoid features. It is important to be aware of this caveat in interpreting BerEP4 staining for BCC and SCC. 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187107     DOI: 10.1111/j.1600-0560.2008.01223.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

Review 1.  Intraoral basal cell carcinoma, a rare neoplasm: report of three new cases with literature review.

Authors:  T R Woods; D M Cohen; M N Islam; F J Kratochvil; J C B Stewart; S L Reeder; I Bhattacharyya
Journal:  Head Neck Pathol       Date:  2013-11-08

Review 2.  [Basal cell carcinoma and rare form variants].

Authors:  J Liersch; J Schaller
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 3.  [Therapy of basal cell carcinoma].

Authors:  L Schmitz; T Dirschka
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.